Similarly, in p53-mutated lung cancer, tumor survival relies on PRIM2 (DNA primase subunit 2); its inhibition also precipitates a stable senescence phenotype, further validating the induction of senescence as a viable synthetic lethal approach [123,124]. This evidence concerns the gene PRIM2 and lung cancer.